화학공학소재연구정보센터
검색결과 : 11건
No. Article
1 Over-expression of lysyl oxidase is associated with poor prognosis and response to therapy of patients with lower grade gliomas
Huang SP, Chiou J, Jan YH, Lai TC, Yu YL, Hsiao M, Lin YF
Biochemical and Biophysical Research Communications, 501(3), 619, 2018
2 Oncogenic MicroRNA-20a is downregulated by the HIF-1 alpha/c-MYC pathway in IDH1 R132H-mutant glioma
Xu QF, Ahmed AK, Zhu Y, Wang K, Lv SQ, Li YQ, Jiang YG
Biochemical and Biophysical Research Communications, 499(4), 882, 2018
3 Crystal structures of pan-IDH inhibitor AG-881 in complex with mutant human IDH1 and IDH2
Ma R, Yun CH
Biochemical and Biophysical Research Communications, 503(4), 2912, 2018
4 A high-sensitive HMab-2 specifically detects IDH1-R132H, the most common IDH mutation in gliomas
Fujii Y, Ogasawara S, Oki H, Liu X, Kaneko MK, Takano S, Kato Y
Biochemical and Biophysical Research Communications, 466(4), 733, 2015
5 A novel monoclonal antibody GMab-m1 specifically recognizes IDH1-R132G mutation
Kato Y, Natsume A, Kaneko MK
Biochemical and Biophysical Research Communications, 432(4), 564, 2013
6 IDH1 and IDH2 have critical roles in 2-hydroxyglutarate production in D-2-hydroxyglutarate dehydrogenase depleted cells
Matsunaga H, Futakuchi-Tsuchida A, Takahashi M, Ishikawa T, Tsuji M, Ando O
Biochemical and Biophysical Research Communications, 423(3), 553, 2012
7 Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation
Kaneko MK, Tian W, Takano S, Suzuki H, Sawa Y, Hozumi Y, Goto K, Yamazaki K, Kitanaka C, Kato Y
Biochemical and Biophysical Research Communications, 406(4), 608, 2011
8 Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer
Murugan AK, Bojdani E, Xing MZ
Biochemical and Biophysical Research Communications, 393(3), 555, 2010
9 Glioma-derived mutations in IDH: From mechanism to potential therapy
Fu YJ, Huang R, Du J, Yang RJ, An N, Liang AH
Biochemical and Biophysical Research Communications, 397(2), 127, 2010
10 IDH1 and IDH2 mutations are frequent in Chinese patients with acute myeloid leukemia but rare in other types of hematological disorders
Zou Y, Zeng Y, Zhang DF, Zou SH, Cheng YF, Yao YG
Biochemical and Biophysical Research Communications, 402(2), 378, 2010